AZD6234
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
AstraZeneca · Phase 2 · Active, not recruiting · Enrollment 16
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.